Dr. Erica Schwartz, Donald Trump's third nominee to lead the Centers for Disease Control and Prevention, appeared before the Senate Health, Education, Labor and Pensions Committee on Wednesday for her confirmation hearing, her first public appearance since Trump named her to the post in mid-April NPR.

The hearing convened at 10 a.m. in room 430 of the Dirksen Senate Office Building, according to the committee's own hearing notice Senate HELP Committee. It was a joint nominations hearing, pairing Schwartz's consideration with that of Sean Kaufman, nominated for Assistant Secretary for Preparedness and Response at HHS. The committee posted advance notice of the joint hearing on its website ahead of the session Senate HELP Committee, and Reuters reported the scheduling a week earlier, on July 8 Reuters.

Trump announced Schwartz's nomination on Truth Social in mid-April. She would report to HHS Secretary Robert F. Kennedy Jr. if confirmed NPR. The CDC has gone without a permanent, Senate-confirmed director for most of Trump's second term, a vacancy that has now stretched across two failed or aborted nominations before Schwartz's turn at the witness table.

Schwartz is a retired Rear Admiral in the U.S. Public Health Service Commissioned Corps who holds degrees in medicine, law, and public health. She served as chief medical officer of the U.S. Coast Guard and, during Trump's first administration, as deputy surgeon general. Her career track record inside federal public health leadership is longer than either of Trump's prior CDC picks brought to their hearings.

That track record includes a recent wrinkle that HELP members were expected to press her on. Schwartz posted in support of vaccines on Instagram earlier this year; the account was taken down not long after her nomination was announced NPR. The timing puts her pro-vaccine public record in some tension with Kennedy's broader agenda to remake federal vaccine policy, an agenda that has already run into legal resistance — a federal judge has blocked a number of Kennedy's proposed changes NPR.

Schwartz is the third person Trump has put forward for the CDC directorship since returning to office. The first, Dr. Dave Weldon, saw his nomination withdrawn just before his own confirmation hearing after it became clear he lacked the votes to pass the committee. The second, Susan Monarez, cleared Senate confirmation but was fired by Kennedy after less than a month on the job NPR.

Despite the Instagram episode, Schwartz was generally expected to clear the confirmation process, per NPR's reporting going into Wednesday's hearing. Her military and federal health credentials give her a different profile than Monarez or Weldon carried into their own proceedings, and committee dynamics have not signaled the kind of vote-counting problem that sank Weldon's bid outright.

Dr. Georges Benjamin, head of the American Public Health Association, has been a vocal presence in the broader debate over CDC leadership and Kennedy's policy direction during this stretch of vacancies and turnover at the agency NPR.

Schwartz's hearing did not happen in isolation on the Senate's confirmation calendar. Jay Clayton, nominated for director of national intelligence, and Keith Sonderling, nominated to another Senate-confirmed post, were both under consideration around the same window in July AOL/Reuters.

The pattern at CDC over this term is now three nominees in roughly eighteen months, one withdrawn before a vote, one confirmed and then dismissed within weeks, and a third facing questions about how her own public statements on vaccines line up with her prospective boss's stated agenda. For a committee that will decide whether Schwartz breaks that cycle, the record she brings — Coast Guard, Public Health Service flag rank, a first-term deputy surgeon general post — reads as an attempt to insulate the nomination from the kind of vote-count problems that doomed Weldon. Whether it insulates her from the policy friction that cost Monarez her job inside of a month is a separate question, one the hearing was designed to surface but not necessarily resolve.